| scholarly article | Q13442814 |
| P50 | author | Dea Shahinas | Q29515231 |
| Allison McGeer | Q42226756 | ||
| Donald E Low | Q60650638 | ||
| Dylan R Pillai | Q90667430 | ||
| Kevin Katz | Q102207412 | ||
| P2093 | author name string | Jean Longtin | |
| Christie Vermeiren | |||
| Gurdip Singh Tamber | |||
| P2860 | cites work | mlstdbNet - distributed multi-locus sequence typing (MLST) databases | Q24803948 |
| Protein structure prediction on the Web: a case study using the Phyre server | Q27860664 | ||
| DaliLite workbench for protein structure comparison | Q27860897 | ||
| Features and development of Coot | Q27861079 | ||
| Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin | Q33676380 | ||
| beta-lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins | Q33711242 | ||
| Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci | Q33759572 | ||
| Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada | Q33983637 | ||
| Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. | Q34147694 | ||
| Group B streptococcal infections in elderly adults | Q36233889 | ||
| First molecular characterization of group B streptococci with reduced penicillin susceptibility | Q36803947 | ||
| Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics | Q36804003 | ||
| Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility | Q36993479 | ||
| BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins | Q39470055 | ||
| Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone | Q43214569 | ||
| Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer | Q43555813 | ||
| Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance. | Q53946819 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| Streptococcus agalactiae | Q132949 | ||
| P304 | page(s) | 2983-2985 | |
| P577 | publication date | 2011-03-07 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy | |
| P478 | volume | 55 |
| Q57035529 | A Phase II Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide -Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III |
| Q43125901 | Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples |
| Q35169242 | Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients |
| Q40934042 | Asymptomatic group B streptococcal bacteriuria among pregnant women in Saudi Arabia |
| Q37428706 | Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France. |
| Q33703629 | Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates |
| Q46247272 | Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease. |
| Q92030545 | Determination of surface proteins profile, capsular genotyping, and antibiotic susceptibility patterns of Group B Streptococcus isolated from urinary tract infection of Iranian patients |
| Q35512019 | Effect of Eugenol against Streptococcus agalactiae and Synergistic Interaction with Biologically Produced Silver Nanoparticles |
| Q34037817 | Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study |
| Q28075884 | Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries |
| Q39528009 | High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility |
| Q60396069 | High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan |
| Q40743043 | High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan |
| Q54426775 | High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility. |
| Q47546256 | Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015. |
| Q64227315 | Isolation of group B Streptococcus with reduced β-lactam susceptibility from pregnant women |
| Q89457708 | Microbiological and Susceptibility Profile of Clinical Gram Positive Isolates at a Tertiary Pediatric and Maternity Hospital in Ulaanbaatar, Mongolia |
| Q37363399 | Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan. |
| Q35035805 | Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility |
| Q40673578 | Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland |
| Q37580818 | Salvage Procedures for Management of Prosthetic Joint Infection After Hip and Knee Replacements |
| Q40749371 | Streptococcus agalactiae infection in cancer patients: a five-year study. |
Search more.